Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-01

Clinical Trial Update: Urinary Prostaglandin as a Potential Predictive Marker for Thiazide-induced Hyponatremia

View source ↗

Summary

A University Hospital Basel study is evaluating urinary prostaglandin as a potential predictor for thiazide-induced hyponatremia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Thiazide-induced Hyponatremia (TIH) | Status: RECRUITING